MétaCan
Menu
Back to cohort
Record W2766356879 · doi:10.1186/s13023-017-0718-x

Measuring what matters to rare disease patients – reflections on the work by the IRDiRC taskforce on patient-centered outcome measures

2017· review· en· W2766356879 on OpenAlexfundno aff
Thomas Morel, Stefan Cano

Bibliographic record

VenueOrphanet Journal of Rare Diseases · 2017
Typereview
Languageen
FieldEconomics, Econometrics and Finance
TopicHealth Systems, Economic Evaluations, Quality of Life
Canadian institutionsnot available
FundersNational Institute of Neurological Disorders and StrokeUniversitaire Ziekenhuizen Leuven, KU LeuvenInstituto de Salud Carlos IIIEuropean Organisation for Rare DiseasesPatient-Centered Outcomes Research InstituteKU LeuvenNational Center for Advancing Translational SciencesLeids Universitair Medisch CentrumUniversiteit LeidenInstitut National de la Santé et de la Recherche MédicaleNational Institutes of HealthUniversity of BirminghamMedical Center, University of RochesterNewcastle UniversityUniversity of WashingtonChildren's National HospitalDuchenne Parent ProjectChiesi FarmaceuticiUniversity of RochesterPfizerNorthwestern UniversityIstituto Superiore di SanitàMcMaster UniversityKing's College LondonVrije Universiteit AmsterdamParent Project Muscular DystrophyNational Institute for Health and Care Research
KeywordsPatient-reported outcomeStakeholderOutcome (game theory)DiseaseValue (mathematics)MedicineRare diseasePsychologyMedical educationNursingComputer scienceQuality of life (healthcare)Public relationsPathology

Abstract

fetched live from OpenAlex

Our ability to evaluate outcomes which genuinely reflect patients' unmet needs, hopes and concerns is of pivotal importance. However, much current clinical research and practice falls short of this objective by selecting outcome measures which do not capture patient value to the fullest. In this Opinion, we discuss Patient-Centered Outcomes Measures (PCOMs), which have the potential to systematically incorporate patient perspectives to measure those outcomes that matter most to patients. We argue for greater multi-stakeholder collaboration to develop PCOMs, with rare disease patients and families at the center. Beyond advancing the science of patient input, PCOMs are powerful tools to translate care or observed treatment benefit into an 'interpretable' measure of patient benefit, and thereby help demonstrate clinical effectiveness. We propose mixed methods psychometric research as the best route to deliver fit-for-purpose PCOMs in rare diseases, as this methodology brings together qualitative and quantitative research methods in tandem with the explicit aim to efficiently utilise data from small samples. And, whether one opts to develop a brand-new PCOM or to select or adapt an existing outcome measure for use in a rare disease, the anchors remain the same: patients, their daily experience of the rare disease, their preferences, core concepts and values. Ultimately, existing value frameworks, registries, and outcomes-based contracts largely fall short of consistently measuring the full range of outcomes that matter to patients. We argue that greater use of PCOMs in rare diseases would enable a fast track to Patient-Centered Care.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.620
metaresearch head score (Gemma)0.478
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.620
Threshold uncertainty score0.469

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.6200.478
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.005
Bibliometrics0.0050.006
Science and technology studies0.0070.045
Scholarly communication0.0180.032
Open science0.0120.020
Research integrity0.0200.076
Insufficient payload (model declined to judge)0.0030.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.549
GPT teacher head0.453
Teacher spread0.096 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations206
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueOrphanet Journal of Rare DiseasesSame topicHealth Systems, Economic Evaluations, Quality of LifeFrench-language works237,207